My Profile
James Pethokoukis
Where politics and the economy intersect.
See all posts
Tue 24 Nov 2009 | 15:18 EST
You are here:
Home
>
Business & Finance
>
Stocks
> Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSS
Widgets
Mobile
Podcasts
Newsletters
Your View
Make Reuters My Homepage
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters
Officers and Directors For Parexel International Corporation
Parexel International Corporation (PRXL.O) (Nasdaq)
sector:
Healthcare
.
industry:
Biotechnology
ยท
View
PRXL
on other exchanges
As of 3:00pm EST
12.97
USD
Price Change
+0.09
Percent Change
+0.70%
Analyst Recommendations
Research Another Stock:
Symbol Look-up
Independent Research
|
Broker Research
Summary
Biographies
Basic Compensation
Options Compensation
Name
Total Annual Compensation
Long-Term Incentive Plans
All Other
Fiscal Year Total
As Of 29 Jun 2009
Batt, Douglas
307,000
--
49,671
731,222
Brykman, Kurt
350,000
--
58,433
565,723
Callow, A. Dana
--
--
--
--
Fortune, Patrick
--
--
--
--
Goldberg, Mark
450,000
--
114,136
784,245
Holdener, Eduard
--
--
--
--
Lindop, Christopher
--
--
--
--
Love, Richard
--
--
--
--
Schneider, Ulf
469,165
--
72,817
723,858
Von Rickenbach, Josef
650,000
--
318,190
1,510,740
Winschel, James
365,000
--
76,638
634,581
Zane, Ellen
--
--
--
--
Find out more about PRXL.O
Insider Trading